Physician profile
Lawrence Wang
NPI 1548326168
$12,054.33
in general payments reported to CMS, 2019-2025
22 companies · $1,503 in 2025
The $1,503 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,297 · 2020: $933 · 2021: $1,144 · 2022: $1,963 · 2023: $2,130 · 2024: $1,085 · 2025: $1,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,251 · Entertainment: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.48 |
| Entertainment | $466.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,318.75 | 2019-2025 | Precision7, Precision 1, Wavelight Ex500 Excimer Laser |
| Coopervision INC. | $1,889.44 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,792.67 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $707.73 | 2022-2025 | Infuse, Alden Scleral Zenlens |
| Sun Pharmaceutical Industries INC. | $611.87 | 2019-2022 | |
| Sight Sciences, INC. | $592.88 | 2021-2023 | Tearcare System |
| Optos, INC. | $580.44 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $379.29 | 2023-2025 | |
| Abb Con-Cise Optical Group LLC | $290.57 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $280.17 | 2020-2022 | |
| Abbvie INC. | $276.29 | 2023-2024 | Vuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $275.78 | 2019-2021 | |
| Lombart Brothers, INC. | $251.68 | 2025 | Opd-III |
| Aerie Pharmaceuticals, INC. | $245.82 | 2019-2021 | |
| Visionix USA, INC | $154.69 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $144.55 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $139.57 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Heidelberg Engineering, INC. | $24.78 | 2022 | |
| Dompe US, INC. | $23.95 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $17.93 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.